A Novavax logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. Reuters file photo
Brussels, December 7
The head of the European Medicines Agency (EMA) on Tuesday said that it could soon approve the Covid-19 vaccine developed by U.S. biotech company Novavax.
"The vaccine from Novavax could be authorised in the very near future," Emma Cooke told EU health ministers during a public session of a meeting in Brussels.
— Reuters
![Whatsapp](/Content/images/Homepage_Assets/whatsapp.png)
Join Whatsapp Channel of The Tribune for latest updates.